For instance, Luteinizing Hormone-Releasing Hormone (LHRH) and Human Epidermal Growth Factor Receptor 2 (HER2) have been used as receptor-modified platinum precursor drugs for the treatment of breast cancer by some scholars (Huang et al., 2015; Li et al., 2015). Here, ERBB2 is linked to breast carcinoma.